Capital International Investors’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
– Sell
-207,413
Closed -$6.77M – 415
2020
Q1
$6.77M Buy
207,413
+6,590
+3% +$257K ﹤0.01% 360
2019
Q4
$9.08M Buy
+200,823
New +$8.4M ﹤0.01% 357
2019
Q3
– Sell
-1,037,147
Closed -$44.6M – 406
2019
Q2
$44.6M Sell
1,037,147
-976,502
-48% -$37.6M 0.02% 283
2019
Q1
$77.3M Buy
2,013,649
+960,109
+91% +$36.7M 0.03% 244
2018
Q4
$37.2M Sell
1,053,540
-138,485
-12% -$5.02M 0.02% 273
2018
Q3
$45.9M Buy
+1,192,025
New +$41.6M 0.02% 275
2015
Q4
– Sell
-2,901,146
Closed -$47.6M – 268
2015
Q3
$47.6M Buy
2,901,146
+1,146
+0% +$19.6K 0.09% 191
2015
Q2
$51.3M Hold
2,900,000
– – 0.09% 192
2015
Q1
$51.5M Hold
2,900,000
– – 0.09% 185
2014
Q4
$38.4M Hold
2,900,000
– – 0.08% 195
2014
Q3
$34.2M Hold
2,900,000
– – 0.08% 181
2014
Q2
$37M Hold
2,900,000
– – 0.1% 172
2014
Q1
$39.2M Hold
2,900,000
– – 0.11% 168
2013
Q4
$34.9M Hold
2,900,000
– – 0.11% 166
2013
Q3
$34M Hold
2,900,000
– – 0.15% 150
2013
Q2
$26.9M Buy
+2,900,000
New +$24.6M 0.12% 152

Other funds holding BSX

Capital International Investors's BSX Position: Q2 2020 in Review

Capital International Investors sold out of Boston Scientific (BSX) in Q2 2020, closing a stake of 207,413 shares — an estimated $6.77M sold.

Capital International Investors first reported a position in BSX in Q2 2013 and held it in 16 quarters. The position peaked at $77.3M in Q1 2019. 841 funds tracked by Wall St. Rank hold BSX as of Q2 2020.

  • Capital International Investors reported no remaining Boston Scientific position as of Q2 2020 after selling out during the quarter.
  • Capital International Investors sold 207,413 Boston Scientific shares in Q2 2020, an estimated $6.77M.
  • Capital International Investors first reported a position in Boston Scientific in Q2 2013 and held it in 16 quarters.
  • Capital International Investors's Boston Scientific position peaked at $77.3M in Q1 2019.
  • 841 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2020.

Based on Capital International Investors's 13F filing for Q2 2020, filed 14 Aug 2020.